BIORELIX INC — Form D/A
BIORELIX INC of NEW HAVEN, CT, a company, filed a Form D amendment with the SEC on 2010-01-27. The offering totals $7.5M, of which $5.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-01-27
- Form: D/A
- Accession: 0001373982-10-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $7.5M
- Amount sold: $5.5M
- Remaining: $2.0M
- Investors: 7
- Date of first sale: 2009-07-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-94141
Issuer
- Name: BIORELIX INC
- CIK: 0001373982
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Phone: 203.785.9282
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Philipe R Chambon | Director | New Haven, CT |
| Dov Goldstein | Director | Houston, TX |
| Ronald Lennox | Director | Providence, RI |
| Ronald Lennox | Executive Officer | Providence, RI |
| Campbell Murray | Director | NOVATO, CA |
| William Wiesler | Director | Durham, NC |
| Campbell R Murray | Director | San Diego, CA |
| Jonathan M Lourie | Executive Officer | Boston, MA |
| Philippe R Chambon | Director | New Haven, CT |
| Brian R Dixon, Ph.D | Director | New Haven, CT |
| Brian R Dixon, Ph.D | Executive Officer | New Haven, CT |
| A. Donny Strosberg | Director | New Haven, CT |
| Ronald R Lennox | Director | New Haven, CT |
| Ronald R Lennox | Executive Officer | New Haven, CT |
| William R Wiesler | Director | New Haven, CT |
| Campbell Donny Murray | Director | New Haven, CT |
| Dov R Goldstein | Director | New Haven, CT |
| A. Donny Strosberg | Director | New Haven, CT |
| Phillipe Chambon | Director | New Haven, CT |
Other filings by this issuer (4)
More